Baidu
map
MOL ASPECTS MED 润色咨询

MOLECULAR ASPECTS OF MEDICINE

出版年份：1975 年文章数：861 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：0.4% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1095240, encodeId=36d4109524024, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095239, encodeId=b415109523931, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927205, encodeId=9a7b92e205af, content=没人投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epGodfzQoNkhFby1h0OiavqWFBAmpISg96EzdCYE2EwdQnnhHuxgPsjRCcZfLsuibJvWFuBjj1hWWqw/132, createdBy=8e281930747, createdName=尔宁, createdTime=Thu Feb 25 19:56:52 CST 2021, time=2021-02-25, status=1, ipAttribution=)]
    2021-12-29 衣谷

    摘要一定要描述使用的方法么？

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1095240, encodeId=36d4109524024, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095239, encodeId=b415109523931, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927205, encodeId=9a7b92e205af, content=没人投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epGodfzQoNkhFby1h0OiavqWFBAmpISg96EzdCYE2EwdQnnhHuxgPsjRCcZfLsuibJvWFuBjj1hWWqw/132, createdBy=8e281930747, createdName=尔宁, createdTime=Thu Feb 25 19:56:52 CST 2021, time=2021-02-25, status=1, ipAttribution=)]
    2021-12-28 小动量

    摘要和HIGHLIGHTS的区别？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1095240, encodeId=36d4109524024, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095239, encodeId=b415109523931, content=摘要和HIGHLIGHTS的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927205, encodeId=9a7b92e205af, content=没人投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epGodfzQoNkhFby1h0OiavqWFBAmpISg96EzdCYE2EwdQnnhHuxgPsjRCcZfLsuibJvWFuBjj1hWWqw/132, createdBy=8e281930747, createdName=尔宁, createdTime=Thu Feb 25 19:56:52 CST 2021, time=2021-02-25, status=1, ipAttribution=)]
    2021-02-25 尔宁

    没人投吗？

    0

共5条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map